ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681636 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681636; 2) Community: the network communities that were significantly associated with the response to NSC 681636; 3) Molecule: the relationships between components within communities and NSC 681636; 4) MDR: the compounds that were significantly associated with the NSC 681636.

NSC Compound Enrichment Correlation
NSC 109836 Null 0.0178844438004195 0.23536947
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.0178844438004195 0.56850454
NSC 294980 N,N-Bis(2-chloroethyl)-p-toluidine 0.0178844438004195 0.74636909
NSC 302991 Camptothecin Derivative 0.0178844438004195 0.77603642
NSC 622070 Null 0.0178844438004195 0.018412775
NSC 639364 2,9-Dimethylellipticinium acetate 0.0178844438004195 0.14861545
NSC 641225 Null 0.0178844438004195 0.33669019
NSC 648365 Insulin-Methotrexate conjugate 0.0178844438004195 0.58041325
NSC 693167 Null 0.0183522248172065 0.57149834
NSC 696652 Null 0.0183522248172065 0.14461097
Total:71  Current:31    [First] [Prev] [Next] [Last]